Why are these markets nevertheless viewed as engaging locations to promote medications, despite the risks? To find out, our recent review surveyed thirteen darknet drug vendors, via online encrypted interviews. They gave us a range of causes.In MAPS’s situation, the health practitioner concerned is Dr. Michael Mithoefer, a psychiatrist primarily